Diffusion and adoption of the surgical robot in urology.
Robotic surgery
da Vinci robot
intuitive surgical
robotic prostatectomy
technology adoption
Journal
Translational andrology and urology
ISSN: 2223-4691
Titre abrégé: Transl Androl Urol
Pays: China
ID NLM: 101581119
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
23
6
2021
pubmed:
24
6
2021
medline:
24
6
2021
Statut:
ppublish
Résumé
Over the last two decades, robotic surgery has become a mainstay in hospital systems around the world. Leading this charge has been Intuitive Surgical Inc.'s da Vinci robotic system (Sunnyvale, CA, USA). Through its innovative technology and unique revenue model, Intuitive has installed 4,986 robotic surgical systems worldwide in the last two decades. The rapid rate of adoption and diffusion of the surgical robot has been propelled by many important industry-specific factors. In this review, we propose a model that explains the successful adoption of robotic surgery due to its three core groups: the surgeon, the hospital administrator, and the patient.
Identifiants
pubmed: 34159097
doi: 10.21037/tau.2019.11.33
pii: tau-10-05-2151
pmc: PMC8185660
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
2151-2157Subventions
Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Informations de copyright
2021 Translational Andrology and Urology. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau.2019.11.33). The series “Controversies in Minimally Invasive Urologic Oncology” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Références
Nature. 2001 Sep 27;413(6854):379-80
pubmed: 11574874
J Endourol. 2009 Apr;23(4):627-33
pubmed: 19358686
Eur Urol. 2001 Jul;40(1):70-4
pubmed: 11528179
Eur Urol. 2013 Sep;64(3):361-9
pubmed: 23498062
JAMA. 2009 Oct 14;302(14):1557-64
pubmed: 19826025
Urology. 2009 Jan;73(1):167-70; discussion 170-1
pubmed: 18829076
Health Aff (Millwood). 2012 Apr;31(4):760-9
pubmed: 22492893
Urol Oncol. 2016 Jun;34(6):255.e1-5
pubmed: 26935867
BJU Int. 2015 Jun;115(6):929-36
pubmed: 24958338
Eur Urol. 2003 Sep;44(3):337-9
pubmed: 12932932
Urology. 1997 Dec;50(6):854-7
pubmed: 9426713
Eff Clin Pract. 1999 Nov-Dec;2(6):277-83
pubmed: 10788026
Cochrane Database Syst Rev. 2017 Sep 12;9:CD009625
pubmed: 28895658
Lancet Oncol. 2018 Aug;19(8):1051-1060
pubmed: 30017351
Urology. 2012 Jul;80(1):126-9
pubmed: 22608294
J Clin Oncol. 2014 May 10;32(14):1419-26
pubmed: 24733797
JAMA Surg. 2016 Nov 1;151(11):1001-1002
pubmed: 27463102
Surg Laparosc Endosc Percutan Tech. 2002 Feb;12(1):6-16
pubmed: 12008765
Prostate. 1999 Apr 1;39(1):71-5
pubmed: 10221270
Urology. 2002 Nov;60(5):864-8
pubmed: 12429317
BJU Int. 2001 Mar;87(4):408-10
pubmed: 11251539
BJU Int. 2014 Oct;114(4):617-29
pubmed: 24053179
J Urol. 2001 Jun;165(6 Pt 1):1964-6
pubmed: 11371890
J Laparoendosc Adv Surg Tech A. 1997 Dec;7(6):369-73
pubmed: 9449087
Eur Urol. 2014 Feb;65(2):316-24
pubmed: 22981673
Eur Urol. 2001 Jul;40(1):75-83
pubmed: 11528180
BJU Int. 2003 Aug;92(3):232-6
pubmed: 12887473
Urology. 2001 Dec;58(6):893-8
pubmed: 11744453
Urology. 2019 Feb;124:309
pubmed: 30367924
Med Care. 1995 Mar;33(3):256-71
pubmed: 7861828
BJU Int. 2010 Jun;105(11):1531-5
pubmed: 19874301
J Robot Surg. 2010 Sep;4(3):141-7
pubmed: 27638753
J Urol. 2003 Nov;170(5):1738-41
pubmed: 14532766
Urology. 2006 Jan;67(1):199
pubmed: 16413370
J Robot Surg. 2019 Apr;13(2):293-299
pubmed: 30062641
Urology. 2004 Nov;64(5):914-8
pubmed: 15533477